Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Human papillomavirus (HPV)
Yellow fever
Adults
2022
Clear all
Type of publications
Systematic reviews (SYSVAC)
(268)
Topics
Available to download in languages
Regions
Africa
(7)
Americas
(6)
Eastern Mediterranean
(1)
Europe
(1)
South-East Asia
(2)
Western Pacific
(8)
Countries
Diseases
COVID-19
(243)
Human papillomavirus (HPV)
(23)
Yellow fever
(2)
Cholera
(1)
Hepatitis A
(1)
Hepatitis B
(4)
Herpes zoster
(4)
HIV / AIDS
(2)
Influenza
(20)
Measles
(1)
Mumps
(1)
Pneumococcal disease
(8)
Rubella
(1)
Smallpox
(1)
Tetanus
(1)
Tuberculosis
(1)
Zika
(1)
Vaccine topics
Acceptance
(31)
Administration
(39)
Coverage
(9)
Economic aspects
(3)
Efficacy/effectiveness
(86)
Ethical issues
(1)
Safety
(142)
Target population
Adults
(268)
Adolescents
(123)
All age groups
(228)
Children
(41)
Healthcare workers
(80)
Newborn
(15)
Older adults
(195)
Parents/caregivers
(23)
Pregnant women
(44)
Travellers
(2)
Publication date
2022
(268)
2023
(84)
2021
(138)
2020
(76)
2019
(12)
2018
(12)
2017
(14)
2016
(18)
2015
(15)
2014
(17)
2013
(5)
2012
(8)
2011
(1)
268 results found
2022
∙
Efros, O. Anteby, R. Halfon, M. Meisel, E. Klang, E. Soffer, S.
Efficacy and Safety of Third Dose of the COVID-19 Vaccine among Solid Organ Transplant Recipients: A Systemic Review and Meta-Analysis
2022
∙
Rinaldi, I. Pratama, S. Wiyono, L. Tandaju, J. R. Wardhana, I. L. Winston, K.
Efficacy and safety profile of COVID-19 mRNA vaccine in patients with hematological malignancies: Systematic review and meta-analysis
2022
∙
Diallo, A. Carlos-Bolumbu, M. Diallo, M. H. Makinson, A. Galtier, F.
Efficacy of approved vaccines to prevent COVID-19: a systematic review and network meta-analysis of reconstructed individual patient data from randomized trials
2022
∙
Perez Navarro, A. Pilkington, V. Pepperrell, T. Mirchandani, M. Levi, J. Hill, A.
Efficacy of Approved Versus Unapproved Vaccines for Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Randomized Blinded Clinical Trials
2022
∙
Kumar, S. Saikia, D. Bankar, M. Saurabh, M. K. Singh, H. Varikasuvu, S. R. Maharshi, V.
Efficacy of COVID-19 vaccines: a systematic review and network meta-analysis of phase 3 randomized controlled trials
2022
∙
Ren, X. Hao, Y. Wu, B. Jia, X. Niu, M. Wang, K. Li, Z.
Efficacy of prophylactic human papillomavirus vaccines on cervical cancer among the Asian population: A meta-analysis
2022
∙
Li, Z. Liu, S. Li, F. Li, Y. Li, Y. Peng, P. Li, S. He, L. Liu, T.
Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis
2022
∙
Oh, S. Purja, S. Shin, H. Kim, M. S. Park, S. Kronbichler, A. Smith, L. Eisenhut, M. Shin, J. I. Kim, E.
Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Randomized Control Trials in the Pre-Delta Era: A Systematic Review and Network Meta-Analysis
2022
∙
Külper-Schiek, W. Piechotta, V. Pilic, A. Batke, M. Dreveton, L. S. Geurts, B. Koch, J. Köppe, S. Treskova, M. Vygen-Bonnet, S. Waize, M. Wichmann, O. Harder, T.
Facing the Omicron variant-how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review
2022
∙
Shin, H. Jeon, S. Cho, I. Park, H.
Factors Affecting Human Papillomavirus Vaccination in Men: Systematic Review
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register